ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_17_length_202121_cov_137.937_1 # 2 # 172 # -1 # ID=17_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.526	NODE_17_length_202121_cov_137.937_1 	2	172	-	Strict	400	115.546	ErmX	96.49	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCTGCATACGGACACGGCCGTCACGAACATGGCCAAAATTTTCTCACCGACCACAAGTTCATCAACTCCATCATCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATAGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATA	MSAYGHGRHEHGQNFLTDHKFINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAI	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	22.53	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_117_length_50948_cov_121.579_51 # 50211 # 50948 # -1 # ID=117_51;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.572	NODE_117_length_50948_cov_121.579_51 	50211	50948	-	Strict	400	353.599	ErmX	96.11	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAACTCACACAAGAAACCTCCTCGGCGACGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGAGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTTGGTTCCCGGGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGATGACCCGAAGATTCCGATAAAGCAGCGCAAAGCCTTTCAAGCGATGGTGCACACCGTTTTCACCGCCCGGGGCCGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGATGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGTGCACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAATCCGGCGGCGTTAA	GPGSGALTHPMAHLGRAITAVEVDAKLAAKLTQETSSATVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVDDPKIPIKQRKAFQAMVHTVFTARGRGIGEILRRAGMFSSRSETQSWLRSRGIDPATLPPRLCTSDWIDLFQVTGSSSPHHRPISPSGSSQRPPQRKNRIRRR	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	96.84	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_279_length_30282_cov_27.1769_33 # 29326 # 30282 # -1 # ID=279_33;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.404	NODE_279_length_30282_cov_27.1769_33 	29326	30282	-	Strict	1200	654.44	tetQ	98.11	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TTTCGAATCGGAGATTATTTAGGTGCTAAACCTTGTTTGATTCAAGGGTTATCTCGTCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAGACAGGCCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACACAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTCAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTGAATAAGATTATTCAGATCGAAGTGCCGCCCAACCCTTATTGGGCCACAATAGGGCTGACTATTGAACCCTTACCGTTAGGGACAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACTGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGACATCCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAATCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTACGCCTCAGAAGTAAGTTCATACACTAAGGGCTTAGGCGTTTTTATGGTTAAGCCATGCGGGTATCAAATAACAAAAGGCGATTATTCTGATAATATCCGTATGAACGAAAAAGATAAACTTTTATTCATGTTTCAAAAATCAATGTCATCAAAATAA	FRIGDYLGAKPCLIQGLSRQHPALKSSVRPDRPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTIEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQSASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	48.40	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_353_length_26571_cov_5.44302_9 # 9777 # 10256 # -1 # ID=353_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.323	NODE_353_length_26571_cov_5.44302_9 	9777	10256	-	Loose	550	24.2534	GES-3	34.78	3002332	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GES beta-lactamase	ATGAAAAAATTATTATTGTTCGCAGCTGGTTTGATGTTGACAGCTTGTGGGGACGATATTGTTAGCATTGATGACAGAGGCGTTGTATTTTTTGGGAATTTATATATACAAGAGTTATCAAAAAACAAGCAATTCTCCTATGCCAGCATTATGTTATCTGATGCACAGGGAATAGGTGATTTTAAATCGATTGATTTAGATATAGTTGGAGAAAAGTCTGAAAGTAAATGCTTGCGCGATACGGAGATCTTGATTAACAATAAAAGATTGCAGCCAATTACTGTAAAATTAGAAGAAAGAGGTGATCGTAAACTATCTTATAGAGCTAAATATTCGTTTGCTGAATACCTTGAATTTTTTGTGAAAAATAACAAAGTTATGATTAGTAGTTGTGGTATTAATCATGTTTTGACCGATAATGAAAAGATGGGTCTCGCAGAGATTACTAAAGCATGGATAAAATTTACAGATGAGAAGTAA	MKKLLLFAAGLMLTACGDDIVSIDDRGVVFFGNLYIQELSKNKQFSYASIMLSDAQGIGDFKSIDLDIVGEKSESKCLRDTEILINNKRLQPITVKLEERGDRKLSYRAKYSFAEYLEFFVKNNKVMISSCGINHVLTDNEKMGLAEITKAWIKFTDEK	MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRFAMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQAAVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIAMARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRNDIGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK	55.40	gnl|BL_ORD_ID|209|hsp_num:0	223
NODE_389_length_25222_cov_7.08694_5 # 3134 # 3760 # 1 # ID=389_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.386	NODE_389_length_25222_cov_7.08694_5 	3134	3760	+	Loose	400	23.8682	Erm(47)	51.85	3003908	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTGGTTAAGTTTTTATAATAAAAAGGGAATCGGCGATACGTTATTATTAACAAGCGGAACAGCAAGCCGTTACGATGTCGAATATGAGAAAAAAGGAAATGTGACTCAAGTCTTTGTTCGTGAGTCAAAAGAAGTTCTAGGCTATAATATTGAAAAGATTTCTGAAGTGATTTCATTTGAAGAAGATGGACAACAAATCTTAACTCCTGAGCAACAAGAAGTTGTAAAAGGATTGATTGAAAAAGCTGGGTTTGATGTTTCAACTTTAGATTTAACGCCGGAAGATGCACTTGTAGTTGGATACGTTGAAAGTTGCGTAGATCATGAAGATTCAGACCACCTACATGTAACAATGACACGAGTAAGTGACTCTGAAGTGTTACAAATCGTCTGCGGAGCACCTAACGTAAAAGTAGGTCAAAAAGTAGTCGTTGCAAAAACTGGTACAGTAATGCCAAGCGGTGCCATCATTTGGGCTGGAGAATTACGCGGAGTGGCTAGTCACGGAATGCTTTGCTCAGCACGTGAATTAGGATTAGAAAATGCACCAGCGAAAAAAGGAATCTTAGTATTAGATGATGCGACTCCAGTAGGGACGCCATTTAAATCATTAAACTTACAATAA	MWLSFYNKKGIGDTLLLTSGTASRYDVEYEKKGNVTQVFVRESKEVLGYNIEKISEVISFEEDGQQILTPEQQEVVKGLIEKAGFDVSTLDLTPEDALVVGYVESCVDHEDSDHLHVTMTRVSDSEVLQIVCGAPNVKVGQKVVVAKTGTVMPSGAIIWAGELRGVASHGMLCSARELGLENAPAKKGILVLDDATPVGTPFKSLNLQ	MNRKSVRFGQNFVTSINDINKICKKIDVNSNDVYFEIGPGKGHFTQYFVERAKEVIAIEIDSELIPILNNKFSDLDNIKIINHDFMSYELPSTFKYKVFGNIPFNLSTSIIRKLSLEKYADEIYLIVELGFAKRLEDLNRKMGLMLAPFYEISILYNIPKRYFHPIPSVEVVLIKLKRTSYNMSMKEYIKYEDFIEKWVKKDYNVLFTKNQLKQAIRYGNIDNLRILKVDQILSIFESYKLFNGLK	84.55	gnl|BL_ORD_ID|2191|hsp_num:0	2387
NODE_431_length_23894_cov_3.23373_1 # 2 # 226 # 1 # ID=431_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.671	NODE_431_length_23894_cov_3.23373_1 	2	226	+	Loose	900	25.7942	emrY	34.21	3000254	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GACCTCGCCTCTGCCGACCTCGTCGTCGTCGCCGAACGGTTCCACATCGGCAGGCTCGAACAGCTCTGCCCCGACGCCAACTACGTCCTCATCAACGACTTCAACCCCGCGATGCCGAAGGGACAGGACCTCGACGACCCCTGGTACGGTCCCGCCTCCGGGTTCCGCAGCACCTTGGCCGACATCGAGGCCGCCATGCCGGGAATCCTCGACGCCCTCGCCTGA	DLASADLVVVAERFHIGRLEQLCPDANYVLINDFNPAMPKGQDLDDPWYGPASGFRSTLADIEAAMPGILDALA	MAITKSTPAPLTGGTLWCVTIALSLATFMQMLDSTISNVAIPTISGFLGASTDEGTWVITSFGVANAIAIPVTGRLAQRIGELRLFLLSVTFFSLSSLMCSLSTNLDVLIFFRVVQGLMAGPLIPLSQSLLLRNYPPEKRTFALALWSMTVIIAPICGPILGGYICDNFSWGWIFLINVPMGIIVLTLCLTLLKGRETETSPVKMNLPGLTLLVLGVGGLQIMLDKGRDLDWFNSSTIIILTVVSVISLISLVIWESTSENPILDLSLFKSRNFTIGIVSITCAYLFYSGAIVLMPQLLQETMGYNAIWAGLAYAPIGIMPLLISPLIGRYGNKIDMRLLVTFSFLMYAVCYYWRSVTFMPTIDFTGIILPQFFQGFAVACFFLPLTTISFSGLPDNKFANASSMSNFFRTLSGSVGTSLTMTLWGRRESLHHSQLTATIDQFNPVFNSSSQIMDKYYGSLSGVLNEINNEITQQSLSISANEIFRMAAIAFILLTVLVWFAKPPFTAKGVG	14.45	gnl|BL_ORD_ID|507|hsp_num:0	540
NODE_802_length_16802_cov_20.9194_1 # 2 # 115 # 1 # ID=802_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	NODE_802_length_16802_cov_20.9194_1 	2	115	+	Strict	650	20.0162	vanE	100.0	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	CAGATGCGGGATGCCGGTGGTGGTTACGCCTGTGAGGACGCGTTTCTTGCTCATGGGGATATCCTTAATGGCTCAAGGTCGTCTGAAAATGAAATAGGGATGGATTATACCTGA	QMRDAGGGYACEDAFLAHGDILNGSRSSENEIGMDYT	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	10.51	gnl|BL_ORD_ID|1539|hsp_num:0	1617
NODE_929_length_15405_cov_16.4973_13 # 9192 # 10409 # 1 # ID=929_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_929_length_15405_cov_16.4973_13 	9192	10409	+	Strict	800	778.474	mefA	96.05	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGTTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTVFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_929_length_15405_cov_16.4973_14 # 10529 # 11992 # 1 # ID=929_14;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_929_length_15405_cov_16.4973_14	10529	11992	+	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_1313_length_12533_cov_37.6439_3 # 3214 # 4029 # 1 # ID=1313_3;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.608	NODE_1313_length_12533_cov_37.6439_3	3214	4029	+	Perfect	500	528.865	sul2	100.0	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic; sulfone antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	100.00	gnl|BL_ORD_ID|910|hsp_num:0	952
NODE_1794_length_10187_cov_4.43831_11 # 10118 # 10186 # -1 # ID=1793_11;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.580	NODE_1794_length_10187_cov_4.43831_11 	10118	10186	-	Strict	700	18.8606	vanKI	100.0	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	GGCGAGTTTTTCCACACCAACTGGACAGGCACCGGCGGCGACACTGCTTCCACTGCCTACAACGTTTGA	GEFFHTNWTGTGGDTASTAYNV	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	5.87	gnl|BL_ORD_ID|2117|hsp_num:0	2245
NODE_2036_length_9401_cov_22.1683_6 # 7235 # 7420 # -1 # ID=2035_6;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.323	NODE_2036_length_9401_cov_22.1683_6 	7235	7420	-	Loose	1000	23.0978	mecD	34.78	3004185	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam	antibiotic target replacement	methicillin resistant PBP2	ATGAGCTTAACAAATTGTCCCGCTTGTCAAAAGCAAATCAGTAATTCAGCAGAAACGTGTCCTCATTGTGGACATCCTATCAAAAAAATAAGAGAGCAACAAAACTCTCTTGTAACAATGATTGTTATTATTGTTGTATGTTTAATAGCGTTCTTTGTTATCAAATTGCAAGGTTTATTCAAATGA	MSLTNCPACQKQISNSAETCPHCGHPIKKIREQQNSLVTMIVIIVVCLIAFFVIKLQGLFK	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	9.00	gnl|BL_ORD_ID|2329|hsp_num:0	2828
NODE_2162_length_9043_cov_42.9899_8 # 6637 # 9042 # 1 # ID=2161_8;partial=01;start_type=ATG;rbs_motif=AACAA;rbs_spacer=7bp;gc_cont=0.436	NODE_2162_length_9043_cov_42.9899_8 	6637	9042	+	Loose	650	26.5646	vanN	22.41	3002912	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGAGAAATTTTCTATATATTTTTGGGATACTCTTTCTTCATATAACTTATGCACAAGAGCAGCAGATAGCAAAGGATACCCTCACTCCAGTAGCAGTGCAGGATACCCTTTCTCAAGCGCCTACGCTGACGGCGTTGGAAAGAGGACGTGAGTTCGTTATAGGAGGCATAGAAGTCAAAGGGGCAAAGCACTACAATGCACAAACCATTATCGTGGCTTCAGGACTGAAAGTGGGTGATAAGATTACCATTCCCAGCGAACGTTTTACCCGTATCATTCACAAGTTGTGGAAGTATCAGGTGTTCAATGATATAGATATCTATATCGCTAAGATTGAGGGAAATAAGGCTTTCTTGGAGTTTGTTATTCAGGAAATGCCTGAACTCACTGAGGTTAAGATTGAGGGTATCCGCAAAAGAAAAGCCGAAGAGCTACTCAAAAAAATAGAACTGGATAAGGACAAACTCAAAGTCTCTAAAAAGGTCAATGAAAGCCTTATCGCTAAAACCAAATCCTATATCACCGATAAGTATCGCAAGGAAGGTTTTCTCAATACCAAAGTATATATCACCACACAGCCTGTGGATTCATTGGGTACCAAGGAGCGTATGCTCATTCGTATAGATAGGGGGTATAAGGTGAAGATCAATCATATCTCCTTCGAGGGAAATGAGAAATTTGCAGATAGCAAGCTGCGCAGGCAGATGAAAAAGACCAAGCAACGTTTCTTTGGTCGTTTCTGGAAACGCTCTAAGTACGTACAAGATAAGTATAACGAGGACTTGGCTTCGCTCATTGACTTCTATAAAGAAAATGGATATCGTGATGCTCGTGTAAAACGCGATACGCTCTATGACGGAAAAGAGAATATTGACCTTAAAATCTCTTTGGAGGAAGGACGCAAATACTACTTCGGGGATATCAAGTTCTTAGGGAATACTATTTATAGTAACCAGATGCTTAGCCATATTCTAGGGCTGAAAAAAGGGGAAGTATATAATGGGGTACAGTTGCGCAATCGTATCAATGACCCTAAAGACCCCGATGCCAATAGCATCTCCAACCTATACCAGAATACGGGTTACCTCTTCTCTCAGATCAATCCTGTTGAGACTTCGGTAGTCAATGACACTATCAACTTTGAGGTACGTATCCATGAGGGTAAGCAAGCACACTTTAATAATATAACGGTAACAGGTAATAATATCACCAACGATAGGGTGATCTACCGTGAGATGCGTACCCGTCCTGGGTATCTTTACTCCAAAGAGGACGTAATACGTACAGTACGTGAGCTTTCTCAGTTGGGTATCTTCGATGCACAGAGTATCAACCCTCAGATCAAGAATCCTGACCCGAATTCTGGAACTGTAGATCTTGAATATGGTCTTACCGATAGTGGTTCCTCCAGCCAGATACAACTACAAGGTGGTTATGGTGGGGGTGGCTTCATGGGTACCCTAGGGTTGAACTTTAACAACTTCTCCATACAAAATATATTTGACAAGAAGTCTTATCGTCCGCTTCCTATGGGGGATGCCCAAAAGCTAGCCCTGAACGTGAGTGTGGGTCGTGCTTATAGGGTAGGTAGCTTCTCCTTTATGGAACCTTGGTGGGGAGGGGAGCGACCTGTACAGTTCTCTCTCGGCTTCAACTATTCGGTAAGCTATGATTATAACTACTATACCTATGATGTGGATAAGAGCAAGCGCTTCTATATCACAGGGGTATATTTGGGATTGGCCAAACGCCTTCAAGTGCCTGATGACTATTTCCAACTCTCTCAGAACATAAGCTATAACTATTATGACTTGAGAAACTATAACACTACGCTCTTTACCTTCGGGAACGGACATGCCAATGCCTTGGCGTACACGGTCTCCCTAAGCCGACGCTCTAGCGGTCCTAACCCTATCTTCCCTCTCGGAGGAAGTGATTTTACCATTACCGCCAAGCTCACCCCTCCTTATTCCTTGTTCAACGGGGTAGATTATAAGTCACTTATGGAACAACGCAATGTAGCAGAAGCCAATGGCAATGCCAATCGTATTTCCGAGATTGACCAAGAGCGATTTAAGTGGTTGGAGTTCTATAAGTTACGTTTGCAAGGAAACTGGTACTTGAATCTGGTAGATAAGCTTGTGTTGCGCCCTTCGGTAGACTTCGGTTACTTGGGTTACTATAATAGGGACAGAGGTACCGTGCCTTTCGAACGCTTCATGGTAGGGGGTGACGGTATGTCCTACAACTCCCTCGAAGGACGTGAATACATACAGATGCGCGGTTATCCGAACCAATCTCTATCGGCACGCGACGGAGATGTGATTTATAATAAGTTCTCTCTCGAACTGCGATACCCTATCACCCTCAAGCCTATGGCTTCTATTTATGGATTGGTATTTGCC	MRNFLYIFGILFLHITYAQEQQIAKDTLTPVAVQDTLSQAPTLTALERGREFVIGGIEVKGAKHYNAQTIIVASGLKVGDKITIPSERFTRIIHKLWKYQVFNDIDIYIAKIEGNKAFLEFVIQEMPELTEVKIEGIRKRKAEELLKKIELDKDKLKVSKKVNESLIAKTKSYITDKYRKEGFLNTKVYITTQPVDSLGTKERMLIRIDRGYKVKINHISFEGNEKFADSKLRRQMKKTKQRFFGRFWKRSKYVQDKYNEDLASLIDFYKENGYRDARVKRDTLYDGKENIDLKISLEEGRKYYFGDIKFLGNTIYSNQMLSHILGLKKGEVYNGVQLRNRINDPKDPDANSISNLYQNTGYLFSQINPVETSVVNDTINFEVRIHEGKQAHFNNITVTGNNITNDRVIYREMRTRPGYLYSKEDVIRTVRELSQLGIFDAQSINPQIKNPDPNSGTVDLEYGLTDSGSSSQIQLQGGYGGGGFMGTLGLNFNNFSIQNIFDKKSYRPLPMGDAQKLALNVSVGRAYRVGSFSFMEPWWGGERPVQFSLGFNYSVSYDYNYYTYDVDKSKRFYITGVYLGLAKRLQVPDDYFQLSQNISYNYYDLRNYNTTLFTFGNGHANALAYTVSLSRRSSGPNPIFPLGGSDFTITAKLTPPYSLFNGVDYKSLMEQRNVAEANGNANRISEIDQERFKWLEFYKLRLQGNWYLNLVDKLVLRPSVDFGYLGYYNRDRGTVPFERFMVGGDGMSYNSLEGREYIQMRGYPNQSLSARDGDVIYNKFSLELRYPITLKPMASIYGLVFA	MKKIALIFGGTSAEYEVSLKSAASVLSVLENLNVEIYRIGIASNGKWYLTFSDNETIANDLWLQDKKLNEITPSFDGRGFYDQAEKVYFKPDVLFPMLHGGTGENGTLQGVFECMQIPYVGCGVASSAICMNKYLLHQFAKSVGVMSTPTQLISSTDEQQVIKNFTELYGFPIFIKPNEAGSSKGISKVHTEAELTKALTEAFQFSQTVILQKAVSGVEIGCAILGNDQLLVGECDEVSLATDFFDYTEKYQMTTAKLTVPAKIPVATSREIKRQAQLLYQLLGCQGLARIDFFLTEAGEILLNEINTMPGFTNHSRFPAMMAATGITYQELISTLITLAEDK	233.82	gnl|BL_ORD_ID|149|hsp_num:0	164
NODE_2608_length_7982_cov_8.51848_1 # 2 # 79 # -1 # ID=2607_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.410	NODE_2608_length_7982_cov_8.51848_1 	2	79	-	Strict	400	20.4014	catB10	100.0	3003110	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAGAAAAGTATTAAGATTTTTGTTGCCCGATAGGCAACAGCGTTGTAGCACAGCCGCGTTTTTATTAGTGGCTCGT	MRKVLRFLLPDRQQRCSTAAFLLVAR	MTNYFESPFKGKLLADQVKNPNIKVGRYSYYSGYYHGHSFDECARFLLPDRDDIDQLIVGSFCSIGTGASFIMAGNQGHRYDWASSFPFFYMKEEPAFSGALDAFQKAGDTVIGSDVWIGSEAMIMPGINVGHGAVIGSRALVTKDVEPYTIVGGNPAKPIKKRFSDEEIAMLLKMNWWDWPTEKIEEAMPLLCSSNIVGLHRYWQGFAV	12.38	gnl|BL_ORD_ID|591|hsp_num:0	628
NODE_3523_length_6360_cov_2.77193_3 # 1465 # 1608 # -1 # ID=3519_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.500	NODE_3523_length_6360_cov_2.77193_3 	1465	1608	-	Strict	690	20.4014	MexJ	100.0	3003692	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAAATAGTTTTAAGTTTACTGGCGGCCAGCTCGCTAATGATGGCCGATAACGATCTAATAATGGNNNNNNNNNNCTACTACAACGAGTACCGCCGATACCGGACTGCTAGACGCGATGGTGCCGGCGTACAAGGCTAA	MKKIVLSLLAASSLMMADNDLIMXXXXYYNEYRRYRTARRDGAGVQG	MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE	12.81	gnl|BL_ORD_ID|2085|hsp_num:0	2205
NODE_3994_length_5743_cov_25.3878_1 # 2 # 94 # -1 # ID=3986_1;partial=10;start_type=ATG;rbs_motif=TAAA;rbs_spacer=9bp;gc_cont=0.527	NODE_3994_length_5743_cov_25.3878_1 	2	94	-	Loose	400	20.0162	ErmF	47.37	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGGTAACAAAAAACAAGTCGCCGTCAGCTTTCTCGGCACGGTATTGGACAGCGGTTTCGGTCAAGGGCGTTGGCAGAAGTGGCGGCCGAAT	MGNKKQVAVSFLGTVLDSGFGQGRWQKWRPN	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	11.65	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_4053_length_5674_cov_2.49021_1 # 1 # 72 # -1 # ID=4045_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=6bp;gc_cont=0.333	NODE_4053_length_5674_cov_2.49021_1 	1	72	-	Strict	650	18.4754	vanL	100.0	3002910	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGAAAAAGGAGAATATGATGAGTCAAAAGATTATTGGGATTGACCTTGGTGGAACTTCTATCAAATTTGCA	MKKENMMSQKIIGIDLGGTSIKFA	MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDIEYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNIPYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKPNEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDEVSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSDNNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG	6.88	gnl|BL_ORD_ID|326|hsp_num:0	349
NODE_4308_length_5435_cov_3.73364_2 # 991 # 1131 # -1 # ID=4299_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.574	NODE_4308_length_5435_cov_3.73364_2 	991	1131	-	Loose	260	20.4014	msrB	47.62	3002818	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTCACCTATGTCGCAGACGCCTCGCCCCACGGGAACGTCAACATCCGTCGGGTATGCGGGAACTGCAGTGGCGTTTTCTACGTCACGTTCAATGCCCAGAACTACAGGTGCCCCCACTGCAACGTCAAGCAGGGGTGA	MFTYVADASPHGNVNIRRVCGNCSGVFYVTFNAQNYRCPHCNVKQG	MANKPSAEELKKNLSEMQFYVTQNHGTEPPFTGRLLHNKRDGVYHCLICDAPLFHSQTKYDSGCGWPSFYEPVSEESIRYIKDLSHGMQRIEIRCGNCDAHLGHVFPDGPQPTGERYCVNSASLRFTDGENGEEING	33.58	gnl|BL_ORD_ID|2258|hsp_num:0	2653
NODE_4365_length_5375_cov_40.3729_4 # 3959 # 4696 # -1 # ID=4356_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.332	NODE_4365_length_5375_cov_40.3729_4	3959	4696	-	Strict	400	491.115	ErmB	98.37	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCATGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTAATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTACTTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCGTTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	98.79	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_5014_length_4795_cov_2.72932_1 # 3 # 134 # -1 # ID=4996_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.379	NODE_5014_length_4795_cov_2.72932_1 	3	134	-	Strict	600	21.1718	Burkholderia pseudomallei Omp38	100.0	3004123	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAACGCGATTCAAGAATCATTTACAGATAAATTATTTGCTAACTATGAAGCAAATGTTAAATACCAAGCGATCGAAAATGCTGCCAGCCATAACGGAATTTTTGCAGCCCTAGAACGTCGCCAAAGCCAT	MNAIQESFTDKLFANYEANVKYQAIENAASHNGIFAALERRQSH	MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQSRFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYDATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFSNNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQGRSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAYTYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTSINQTAATVGLRHRF	11.76	gnl|BL_ORD_ID|2317|hsp_num:0	2786
NODE_5787_length_4291_cov_6.11922_1 # 2 # 127 # 1 # ID=5756_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.563	NODE_5787_length_4291_cov_6.11922_1 	2	127	+	Strict	500	19.631	OXA-53	100.0	3001810	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GGAGGGGAATCAGTTCGGCGCGATGATGCGTCCACGCTGCTGAATGTCCCCTGTGTGCTCCAGAACATCCTGCAGTGCCCATTGCATACGATCGATTCGTTCCGCTCCGATTGGGGTAAATCCTGA	GGESVRRDDASTLLNVPCVLQNILQCPLHTIDSFRSDWGKS	MAIQIFAILFSTFVLATFAHAQDGTLERSDWGKFFSDFQAKGTIVVADERQADHAILVFDQARSMKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVKRSFAGHNKDQDLRSAMRNSTVWVYELFAKEIGDGKARRYLKQIGYGNADPSTSHGDYWIEGSLAISAQEQIAFLRKLYQNDLPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGSMGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIARAILLSIEALPPNPAVHSDAAR	14.91	gnl|BL_ORD_ID|1281|hsp_num:0	1341
NODE_6225_length_4021_cov_3.2466_1 # 9 # 350 # -1 # ID=6187_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.623	NODE_6225_length_4021_cov_3.2466_1 	9	350	-	Loose	400	27.7202	VatI	34.04	3003987	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGAACTCTCGGGTGCTCAAGGGGTCGGTGGCAGTCCTGGCCTCTGTCGCCATTGCTTTTGGCGCGGTCGGGTGCGGCGGGAAACCGAGCAAGGACGCCGTCAAGGCGGGAATCATCAAGATGATCAAGGAGAAGGGTGGCTCCAAGTACGCGGAGGGCGTGCTCAACGACTACGTCGGTTGTGTGGTGGACGGGAGCTACGACAAGGTGAGCTCCGACACCCTCCAGAAACTCGCCGACGGGAAGATCGACGTCAACGCCAAGGCCAGCGACGAGGATGGCAAGGCCGTCGCGGAGGCCGTAACGAAGTGCGCGACCAAGCTGGCCGGTAAGGACAGCTGA	MNSRVLKGSVAVLASVAIAFGAVGCGGKPSKDAVKAGIIKMIKEKGGSKYAEGVLNDYVGCVVDGSYDKVSSDTLQKLADGKIDVNAKASDEDGKAVAEAVTKCATKLAGKDS	MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKLMIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVWIGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKWWDCDIEVINQYIGAIVSGDMDLLRKMRQN	53.81	gnl|BL_ORD_ID|2237|hsp_num:0	2523
NODE_6718_length_3767_cov_26.0779_5 # 3707 # 3766 # 1 # ID=6668_5;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=15bp;gc_cont=0.333	NODE_6718_length_3767_cov_26.0779_5 	3707	3766	+	Strict	1200	43.1282	tetQ	100.0	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAACATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACC	MNIINLGILAHIDAGKTSVT	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	3.04	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_8486_length_3087_cov_28.4077_1 # 2 # 109 # -1 # ID=8344_1;partial=10;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.324	NODE_8486_length_3087_cov_28.4077_1 	2	109	-	Strict	1200	74.7146	tetQ	97.22	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCATTTCGACAATGCATCTATTGTAGTATATTATTGCTTAATCCAAATGAATATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACC	VHFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVT	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	5.48	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_8529_length_3071_cov_2.13097_2 # 309 # 707 # -1 # ID=8385_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.484	NODE_8529_length_3071_cov_2.13097_2 	309	707	-	Loose	1650	25.7942	Streptococcus agalactiae mprF	26.67	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAAATCCCTTACTCCTCTGCAAAATGCCATTTCCATCATTGGCGGTGTACTTCTTATCATCGGAGCACTCCTTCCGCTTGCTGGAGTCTTGGCACAATATGCTCCTTATGTCTTCGCTCTGGGAGCACTCTCTTATGGCGGCACGCAGATTTTGCGCCGTTATGAAGGCAAAAACACCACGATTATCCGACTGCGTCGTCAAGAAATTATCAGTGCTTTCCTTTTGATGGTTAGTGCAGTGCTGATGCTCGTGAGCAGTTTTCGCTTGTTGCCTTTGCAAGGTGGGGAGTGGAAGCTCTGTCTTGCCGTAGCTGTCGTGTTTCAATTATACACCGCCTTCCGTCTTCCCCAAGAGTTGGACAAAGAAGCGCGTCAAAAGGAGCAGAAAAACGGATAA	MKSLTPLQNAISIIGGVLLIIGALLPLAGVLAQYAPYVFALGALSYGGTQILRRYEGKNTTIIRLRRQEIISAFLLMVSAVLMLVSSFRLLPLQGGEWKLCLAVAVVFQLYTAFRLPQELDKEARQKEQKNG	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	15.58	gnl|BL_ORD_ID|2132|hsp_num:0	2283
NODE_9263_length_2874_cov_4.79319_2 # 767 # 2686 # -1 # ID=9076_2;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.411	NODE_9263_length_2874_cov_4.79319_2	767	2686	-	Strict	1200	1201.42	tet32	89.97	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTCGCCCATGTAGACGCAGGAAAAACAACATTGACGGAAAGCCTGCTGTACACCAGTGGAGCGATTGCGGAACAAGGAAACGTGGATAAAGGAACTACAAGAACAGACACTATGATTTTGGAACGGCAGCGCGGAATTACCATTCAGACAGCGGTTACTTCTTTTTGCTGGAATGATTATAAAATCAATATCGTGGACACTCCCGGTCATATGGATTTTTTAACCGAAGCATACCGCTCTTTATCTGTCCTTGACGGAGCTGTTTTAGTCATTTCGGCAAAAGACGGCGTACAGGCACAAACCCGTATATTATTCCATGCGCTTCAGAAAATGGACATTCCGACAATTATCTTTATAAATAAGATAGACCAAAATGGGATCGACCTGCGGCGTGTTTACCAAAGCATTAAAGATAAACTTACCAGTGATATGATTGTCATGCAGGAGGTTTCCCTGTCGCCAAAGATAACCATGACCGATATTTCTGATTTGGACAAATGGGATATGATTATTTCCGGAAGCGATGAACTATTAGAACGATATGTTGCAGAGGATTCTTTGGATATACAGGAATTACAATATGAAAAGTGCAAAAGAACCAGATGCTGCTCTTTGTTTCCTGTTTATCATGGGAGTGCAAAAGACAATTTAGGAACAGAAAAACTGATTGAAGCGATTACAGAAACTTTCATTACAGAAACAGACGATATTCAGTCTGAATTATGTGGATATGTTTTTAAGGTTGAGTATACAGAGCGGAAAAAACGGCTTTCTTATTTACGCCTGTATCATGGGACGCTCCATTTACGGGATACCCTGCTGCTGTCAAAAAAGGAAAAAATAAAGATTACAGAAATGTGTATTCCGTCAAATGGTGAAATCGTCCCGGTTGACCATGCCTGTCCGGGAGAAATTGTTATTTTAGCTGATGATACTTTGAAACTGAACGACATTCTGGGAAATGAAAAACTCCTGCCTCACAAAACACGGATTGATAATCCCATGCCATTACTTCGGACAACGGTAGAGCCGCAAAAGCCGGAGCAAAGGGAAGCCCTGTTAAATGCCCTCACAGAGATTGCTGATACAGACCCTCTTTTGCATTTTGACATTGATACTGTTACACATGAGATTATATTATCTTTTTTGGGAAAAGTACAGTTAGAAGTTATTTGTTCGCTATTAGAAGAAAAATATCATGTGGGCGTGGCTATGAAAGAGCCTTCGGTTATTTATCTGGAAAGACCGCAAAAAAAAGCGAGCTACACGATTCATATTGAAGTGCCGCCGAATCCGTTTTGGGCATCTATTGGTTTGACTGTAACACCGCTTCCTGTTGGAAGCGGAACACAATATAAAAGCGAGGTATCTCTCGGCTATTTAAACCAAAGTTTTCAAAATGCCGTCATGGAGGGTGTGCGTTATGGAATGGAGCAGGGCTTATATGGCTGGGGAGTGACAGACTGCCAAATTTGTTTTGATTATGGAGTTTATTACAGCCCGGTCAGCACCCCCGCTGATTTTCGTTTTCTTGCGCCTGTCGTGTTGGAGCAGGCATTGAAAAAAGCAGGAACACAACTGTTGGAACCATACCTTTCCTTTACCCTTTTTGCACCGCAGGAATATCTTTCACGGGCTTATAATGACGCACCAAAGTATTGCGCAATCATTGAATCAACCAGACTTGAAAAAGATGAAGTTATTTTTAAGGGGGAAATCCCTGCCCGTTGTATTGGTGAATATAGAAATGATTTGAATTTTTATACAAATGGAAGAAGTGTCTGCATTACAGAATTAAAAGGGTATCAGGAAACTTCCGGCGAGCCTGTGTTTCAGCCACGCCGCCCGAACAGCCGTTTAGACAAGATCCGGCATATGTTTCAGAAGATAATGTAA	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFCWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLRRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASYTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	100.00	gnl|BL_ORD_ID|1179|hsp_num:0	1233
NODE_10696_length_2535_cov_11.3081_1 # 198 # 1364 # -1 # ID=10387_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.374	NODE_10696_length_2535_cov_11.3081_1	198	1364	-	Strict	750	799.66	tetX	99.74	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	100.00	gnl|BL_ORD_ID|734|hsp_num:0	776
NODE_13006_length_2140_cov_2.14244_1 # 1 # 195 # 1 # ID=12437_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	NODE_13006_length_2140_cov_2.14244_1 	1	195	+	Loose	275	27.335	AAC(6')-Iaj	35.56	3003677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ACCCGGCCGGACCTGCGTGGGCGGGGTATTGGGACGGTGGCCCTGGCGGCGGTGGTGGACGCGGTGCGCGCCGACCACGTGGGGCCTGACGGGGTGGTGAGCCTGTACGCCAACGACTTCAACGCCCCGGCCCTGGGGCTGTACCGGTCCCTGGGGTTCACCCGGCACGGCACCTTCGCCACGATCCTGCTGTAA	TRPDLRGRGIGTVALAAVVDAVRADHVGPDGVVSLYANDFNAPALGLYRSLGFTRHGTFATILL	MEYSIINIVEQNNYQIDAARILTNTFLDIGNKTWPTIQSAIDEVEECIDLPNICIGLIHNNQLIGWVGLRPMYDKTWELHPLVVRTDYQSKGIGSVLLAEVEKRAREVGIIGIILGTDDEYNKTSLSEITIDENNIFDAIQNIKNIHNHPYEFYQKNGYMIVGIIPNANGLRKPDIWMWKSLLN	34.78	gnl|BL_ORD_ID|2095|hsp_num:0	2191
NODE_13173_length_2111_cov_42.304_3 # 1988 # 2110 # 1 # ID=12571_3;partial=01;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.431	NODE_13173_length_2111_cov_42.304_3 	1988	2110	+	Loose	275	22.7126	AAC(6')-Ie-APH(2'')-Ia	34.78	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	ATGAATAAGGAGACTGAGGCACTCATTGACCGTATTCCCCTACTGAATAAGCTGATTGCTTTTCTTAAGCGTATCCCTCTGGGTAAGGGACAACAATTTTCCCTCTATGACCTATTGGAACTC	MNKETEALIDRIPLLNKLIAFLKRIPLGKGQQFSLYDLLEL	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	8.56	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_13544_length_2059_cov_2.52345_1 # 1 # 192 # 1 # ID=12889_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.443	NODE_13544_length_2059_cov_2.52345_1 	1	192	+	Strict	800	20.7866	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	100.0	3003785	protein homolog model	n/a	n/a	fosfomycin	antibiotic target alteration	murA transferase	AGTTCAAATGGTAAGGTCCTCTTTCACGAATGTTTGAGTGTAAACCCAAACTCCCATCAAGTTGAGAGTGCGGATGAAATCGACATGAGTTGGTTTGAAGGAGTTGAAACAGTAGGAATCTGTGGGGCTACGAGTACGCCAAAATGGCTGATGGAAGAATGCCGTGATGAGATACTCAGGCGTACGAAATAA	SSNGKVLFHECLSVNPNSHQVESADEIDMSWFEGVETVGICGATSTPKWLMEECRDEILRRTK	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	14.19	gnl|BL_ORD_ID|2281|hsp_num:0	2291
NODE_13951_length_2006_cov_2.1061_1 # 20 # 1228 # -1 # ID=13235_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.427	NODE_13951_length_2006_cov_2.1061_1	20	1228	-	Strict	750	778.089	pmrA	97.99	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACAAAGATTAACTGGAAAGATAATCTGCGCATTGCTTGGTTTGGTAATTTTCTGACAGGAGCCAGTATTTCCTTAGTTGTGCCTTTTATGCCTATTTTTGTGGAAAATTTAGGTGTAGGGAGTGATCAAGCTGCTTTTTATGCAGGTTTAGCTATTTCTGTCTCTGCCATTTCTGCGGCACTTTTCTCTCCTATCTGGGGCATCCTTGCTGACAAATACGGTCGAAAACCCATGATGATTCGGGCTGGGATGGCCATGACCATTACTATGGGGGGCTTGGCTTTTGTCCCAAATATTTATTGGTTAATCTTTCTTCGCTTACTAAATGGTGTATTTGCAGGTTTTGTTCCTAACGCCACAGCCTTGATAGCTAGTCAGGTTCCCAAGGAGAAATCAGGCTCTGCTCTTGGGACTTTGTCTACAGGAGTAGTAGCAGGTACTTTAACTGGTCCTTTTATCGGTGGCTTTATCGCAGAATTATTTGGCATTCGTACAGTCTTTTTACTGGTTGGTAGTTTTCTCTTCTTAGCCGCTGTTTTGACTATTTGCTTTATCAAGGAAGATTTTCAACCAGTAGCAAAAGAAAAGGCCATTCCAACAAAGGAATTATTTACATCAGTTAACTATCCCTATCTCTTGGTCAACCTCTTTCTGACCAGTTTTGTCATCCAATTTTCAGCCCAATCAATCGGACCTATCTTAGCTCTGTATGTACGCGACTTAGGCCAGACAGAGAATCTTCTTTTTGTCTCTGGTTTGATTGTATCCAGTATGGGCTTTTCCAGCATGATGAGTGCAGGTGTTATGGGAAAGCTAGGTGACAAGGTGGGCAATCATCGCCTCTTGGTTGTAGCCCAGTTTTATTCAGTCATCATCTATCTCCTCTGTGCCAATGCTTCTAGCCCTCTTCAACTAGGACTTTATCGTTTCCTCTTTGGCTTGGGAACCGGTGCCTTGATTCCCGGAGTTAATGCTCTTCTCAGCAAGATGACACCCAAAGCTGGTATTTCAAGAGTATTTGCCTTCAATCAGGTCTTCTTTTATCTGGGAGGTGTCGTTGGTCCCATGGCAGGTTCTGCAGTAGCAGGCCAATTTGGCTACCATGCAGTCTTTTATGCGACAAGCCTTTGTGTTGCCTTTAGTTGTCTCTTTAACCTTCTTCAATTTCGAACATTATTAAAAGTAAAGGAAATCTCGTGCGAGTAA	MTKINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSDQAAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGMAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAVLTICFIKEDFQPVAKEKAIPTKELFTSVNYPYLLVNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLLQFRTLLKVKEISCE	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	100.75	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_15465_length_1833_cov_8.01406_1 # 2 # 106 # -1 # ID=14481_1;partial=10;start_type=ATG;rbs_motif=AATAA;rbs_spacer=4bp;gc_cont=0.457	NODE_15465_length_1833_cov_8.01406_1 	2	106	-	Loose	1250	20.4014	mecA	30.43	3000617	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam	antibiotic target replacement	methicillin resistant PBP2	ATGCCGCTATATAGAAAGAAAGGTAAGTACTCTATATCCAACAATGTGGGCAGTGTCTGCAAGTCTCTGCCCTTCCGCTTTTGGGAGCTTTTTCCTGTGGCGTGC	MPLYRKKGKYSISNNVGSVCKSLPFRFWELFPVAC	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	5.24	gnl|BL_ORD_ID|1263|hsp_num:0	1321
NODE_16020_length_1778_cov_4.47185_3 # 1639 # 1776 # -1 # ID=14932_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.493	NODE_16020_length_1778_cov_4.47185_3 	1639	1776	-	Strict	1800	20.4014	MexD	100.0	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GGTATACAGTTGTGTACACACGTGTATACTCATCCCTCCTCGGTAGGAGGGATACGCTGGGTATCTCTACACCTAGGATACGGATACTTCTATCTTCGGCTTATGCTCCTTGACGACCTTGCCCTCGCAGTATGGTGA	GIQLCTHVYTHPSSVGGIRWVSLHLGYGYFYLRLMLLDDLALAVW	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	4.31	gnl|BL_ORD_ID|1546|hsp_num:0	1523
NODE_18195_length_1587_cov_2.28329_3 # 1510 # 1587 # 1 # ID=16639_3;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.551	NODE_18195_length_1587_cov_2.28329_3 	1510	1587	+	Strict	790	19.631	tet(40)	100.0	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCATTTAACTACGATAAATATCTGCGAACCGACAAGATGCCCACGCTGTGGTGCTGGGGCTGCGGCGACGGCGTA	MAFNYDKYLRTDKMPTLWCWGCGDGV	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFEIPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	6.40	gnl|BL_ORD_ID|928|hsp_num:0	945
NODE_18321_length_1577_cov_3.54271_4 # 1422 # 1577 # -1 # ID=16728_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.455	NODE_18321_length_1577_cov_3.54271_4 	1422	1577	-	Strict	2090	21.1718	mdsB	100.0	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ACTGTACGTGAAACCTTGCCGGAAGGTTTCCAACGTGCAGAATTCTTGTTGGAGAAGGGCGCAATCGACCAAATCGTCGATCGCCGTTCCATGAAAAAACGTATCAGCGATTTGATTACTTTGTTGCGTCATGAGAGCAAAGTAACTGCTGCTTGA	TVRETLPEGFQRAEFLLEKGAIDQIVDRRSMKKRISDLITLLRHESKVTAA	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	4.83	gnl|BL_ORD_ID|1320|hsp_num:0	1385
NODE_19914_length_1459_cov_2.77991_1 # 1 # 1272 # -1 # ID=17941_1;partial=10;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.528	NODE_19914_length_1459_cov_2.77991_1 	1	1272	-	Strict	1200	859.366	tetW	99.76	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCATTTCAGAACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTTAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGCGCGGGAGGAACAGCAGCGGGTTCAAGACGCCTCCCTGTTCCCAGTCTATCATGGCAGCGCCAAAAATGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGGGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTACGGTTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGACCAAACCCGGCTCCCTCGTAAAAGGTGGCGCGAGGACCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGTTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAAAGGAACCCTCCGTCATCTATATGGAGCGGCCG	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERP	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	66.35	gnl|BL_ORD_ID|364|hsp_num:0	389
NODE_21910_length_1339_cov_114.588_2 # 359 # 1339 # -1 # ID=19393_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.352	NODE_21910_length_1339_cov_114.588_2	359	1339	-	Strict	600	661.759	CfxA3	100.0	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATAAATAATATAAACATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTGATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	INNINMEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	101.56	gnl|BL_ORD_ID|1813|hsp_num:0	1895
NODE_22310_length_1317_cov_75.3146_2 # 436 # 1236 # -1 # ID=19678_2;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.340	NODE_22310_length_1317_cov_75.3146_2	436	1236	-	Strict	400	535.798	ErmF	99.25	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_22407_length_1311_cov_4.46099_3 # 1172 # 1309 # -1 # ID=19750_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.268	NODE_22407_length_1311_cov_4.46099_3 	1172	1309	-	Loose	500	20.7866	OXA-232	33.33	3001778	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	AGAGGGTATTATAGAACAAGATTTTTTAATATAAAAGTGCAAGGAGATTATACTTATTATCTGCTTTCGGCAAAAAAGCCCCTCATAGGTGTAAATAAGATTTATAATAATGAGTTTAATAAGAAAGAAAGATCCTAA	RGYYRTRFFNIKVQGDYTYYLLSAKKPLIGVNKIYNNEFNKKERS	MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTSIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP	16.98	gnl|BL_ORD_ID|173|hsp_num:0	185
NODE_23609_length_1250_cov_2.25439_1 # 3 # 77 # -1 # ID=20575_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.787	NODE_23609_length_1250_cov_2.25439_1 	3	77	-	Loose	200	19.2458	Pseudomonas aeruginosa soxR	52.94	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; acridine dye; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGGGCTTGAGACCCGTGGACTGAGGCGCTCCCACCCGGGGGCCGGCGGCGAGCGGCGAGAGGGGCTGCGC	MSGLETRGLRRSHPGAGGERREGLR	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	16.03	gnl|BL_ORD_ID|2313|hsp_num:0	2775
NODE_24009_length_1233_cov_2.79287_2 # 864 # 1232 # -1 # ID=20854_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.482	NODE_24009_length_1233_cov_2.79287_2 	864	1232	-	Loose	500	23.8682	OXA-178	30.23	3001472	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GAAGCAGGGCGTGATCTGGATAAAAGCTATCTGTGCGAGATCGATTTTTCCAAGCTTAAATTTGAAAATATCGTAGCGGACGTTTATTCGAAATTCCCTAGCGTATCGCGCGATCTAAGCATTTTGGTGCCGAGCGGAATGCGCTTCGAGCAAATCAAAGAGTGTATAGACGCCCTTAAAATTGAGGCGCTAAAGGAGCTTATCCCGAGCGATCTTTACGGCGACGAAAGCCTGGGCGATTCAAAGAGCCTGACGATCAGGCTTGTATTTCAAGACCTTCAAAAAACGCTCTGCGACGAGGAAGTAGCGGGCTTTACCGATAAAATTTTAGCCGCGCTTAGCAGCGAGCTGGGGCTTGGGCTGCGATGA	EAGRDLDKSYLCEIDFSKLKFENIVADVYSKFPSVSRDLSILVPSGMRFEQIKECIDALKIEALKELIPSDLYGDESLGDSKSLTIRLVFQDLQKTLCDEEVAGFTDKILAALSSELGLGLR	MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDSKKRLFPEWEKDMTLGDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	44.53	gnl|BL_ORD_ID|217|hsp_num:0	231
NODE_24580_length_1204_cov_2.26893_1 # 1 # 642 # -1 # ID=21238_1;partial=10;start_type=ATG;rbs_motif=AAA;rbs_spacer=14bp;gc_cont=0.408	NODE_24580_length_1204_cov_2.26893_1	1	642	-	Strict	300	359.377	SAT-4	97.18	3002897	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGGTCGTCATCGTTGCGGTCGAAAAAGCGCAGGTTGATCACGCTTTGAATGCCCAGCTTGACAATGGCTTCGCCATCTTCGGCAACAGGCTGCTCGCTGCGGTAAAGCTTGTCATCGATGCGATAAAAGCAGGGCACCTGAAAGATATCGATAAACCCAGCGAACCATTTGAGGTGATAGGTAAGATTATACCGAGGTATGAAAACGAGAATTGGACCTTTACAGAATTACTCTATGAAGCGCCATATTTAAAAAGCTACCAAGACGAAGAGGATGAAGAGGATGAGGAGGCAGATTGCCTTGAATATATTGACAATACTGATAAGATAATATATCTTTACTACCAAGACGATAAATGCGTCGGAAAAGTTAAACTGCGAAAAAATTGGAACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCAGGGGGCAAGGCATAGGCAGCGCGCTTATCAATATATCTATAGAATGGGCAAAGCATAAAAACTTGCATGGACTAATGCTTGAAACCCAGGACAATAACCTTATAGCTTGTAAATTCTATCATAATTGTGGTTTCAAAATCGGCTCCGTCGATACTATGTTATACGCCAACTTTGAAAACAACTTTGAAAAAGCTGTTTTCTGGTAT	MVVIVAVEKAQVDHALNAQLDNGFAIFGNRLLAAVKLVIDAIKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWY	MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF	118.89	gnl|BL_ORD_ID|1544|hsp_num:0	1505
NODE_27819_length_1069_cov_4.97929_2 # 247 # 1008 # 1 # ID=23348_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_27819_length_1069_cov_4.97929_2 	247	1008	+	Loose	500	26.1794	OXA-328	68.42	3001516	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGAAGAAAAAACCTATTCTCTTGCTTTTAGCAGCTTCCGTAGTTTTCCTTCTGTTTTTATCAGCCTGCAGCTCCAATAAGGGAGGCGATACTAATGGTTCCAGTTCCGAAGTGCAAAAAACGAAAGAGGGAATTTATGAGCATCTAAAAAATGCAAAGAATGAAATTTGGTATGTAACTAAGGAAGTATCAAAAACCTCTTATCCTTCTTATATCTATATCTTCAACAAGGGAGAAGTCAAAGGTTATAATTTATTTGATGCTAATATAGAAGGGAAATCTTTCGGAGATTTAGCGCAGATGTCCGATAAGGAAATTATTGATTACTATGAAAGTCAGGAAGGGGCAGCTTTAAAAGGTCTCTCTGAGCAGGCAGATTCGTTTTATGCGAGTATCAATCAAAATGAGGTGTCTAAGGCAACATCTGAAGCGTATAAAAAATACGCAGACGGGAATGGCGAGCTTCCTGCTGTTAAGTACACGGTTAAGCTAGTGACAGATGAAAGTGGGACTGGTGTCGAAAGTGAGAATATCGATATCAATCTCTTGGGTGTCGGGCAACATGCATCAAGAGTTGGAGAATTTCCACATTATACTGCTGTCTTGAAGCATGTAACAAGCACTACTAAGATTTTTGATAGCACCTATAATGGTTTTGAAACAGAGGATGCTGCGAAACCTTTATTTGTTACTCGTAGTAAAAAGCAGTTTGACTTAGATACTACTAAAACAAATGCTAAGGGACTGGAAATAGAATAA	MMKKKPILLLLAASVVFLLFLSACSSNKGGDTNGSSSEVQKTKEGIYEHLKNAKNEIWYVTKEVSKTSYPSYIYIFNKGEVKGYNLFDANIEGKSFGDLAQMSDKEIIDYYESQEGAALKGLSEQADSFYASINQNEVSKATSEAYKKYADGNGELPAVKYTVKLVTDESGTGVESENIDINLLGVGQHASRVGEFPHYTAVLKHVTSTTKIFDSTYNGFETEDAAKPLFVTRSKKQFDLDTTKTNAKGLEIE	MYKKALIVATSLLFLSACSSNTVTQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGKTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGNAMKASAIPVYQELAQRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	92.67	gnl|BL_ORD_ID|576|hsp_num:0	611
NODE_29331_length_1018_cov_98.9294_1 # 2 # 1018 # -1 # ID=24325_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.382	NODE_29331_length_1018_cov_98.9294_1 	2	1018	-	Strict	1200	688.337	tetQ	99.12	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACCGAGAATCTGCTGTTTGCCAGTGGAGCAACGGAAAAGTGCGGCCGTGTGGATAATGGTGACACCATAACAGACTCTATGGATATAGAGAAACGTAGAGGAATTACTGTTCGGGCTTCTACGACATCTATTATCAGGAATGGTGTGAAATGCAATATCATTGACACTCCGGGACACATGGATTTTATTGCGGAAGTGGAGCGGACATTCAAAATGCTTGATGGAGCAGTCCTCATCTTATCCGCAAAGGAAGGCATACAAGCGCAAACAAAGTTGCTGTTCAATACTTTACAAAAACTGCAAATCCCGACAATTATATTTATCAATAAAATTGACCGTGACGGTGTGAATTTAGAGCGTTTGTATCTGGATATAAAAACAAATCTGTCTCAAGATGTCCTGTTTATGCAAACTATTGTCGATGGATTGGTTTATCCGATTTGCTCCCAAACATATATAAAGGAAGAATACAAAGAATTTGTATGCAACCATGACGACAATATATTAGAACGATATTTGGCGGATAGCGAAATTTCACCGGCTGATTATTGGAATACGATAATCGATCTTGTGGCAAAAGCCAAAGTCTATCCGGTACTACATGGATCAGCAATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATCTCTTCTTTTATACTTCCTCCAGAATCAGTCTCAAACAGACTTTCAGCTTATCTCTATAAGATAGAGCATGACCCCAAAGGACATAAAAGAAGTTTTCTAAAAATAATTGACGGAAGTCTGAGACTTCGAGACATTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAGACTATTTATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGGGCCAATGATATCGCGATTGTAGAAGATATGGAAGATTTTCGAATCGGAGATTATTTAGGTGCTAAACCTTGTTTGATTCAAGGGTTATCT	IINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIRNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTIVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGAKPCLIQGLS	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	51.60	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_31501_length_954_cov_6.88098_2 # 882 # 953 # -1 # ID=25638_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.403	NODE_31501_length_954_cov_6.88098_2 	882	953	-	Strict	1000	18.8606	MCR-4	100.0	3004325	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	CGTGACAGCGGCTGCAAAGGTACGCATATTTTTCTGATAATGAGCAAGGAAGAGGAAGAAAAATTGATTTGA	RDSGCKGTHIFLIMSKEEEEKLI	MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY	4.25	gnl|BL_ORD_ID|2367|hsp_num:0	2848
NODE_31945_length_942_cov_2.06088_1 # 2 # 64 # -1 # ID=25907_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.444	NODE_31945_length_942_cov_2.06088_1 	2	64	-	Loose	600	19.2458	SME-4	50.0	3002382	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SME beta-lactamase	ATGCAAGAGCAACCCCAGTTTAAGTCAGGAGTATGGGAAGTCGAACTCAATGTTCGTGACTTC	MQEQPQFKSGVWEVELNVRDF	MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNTFGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGMTLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGDKRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTGSCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID	7.14	gnl|BL_ORD_ID|1533|hsp_num:0	1611
NODE_33613_length_899_cov_8.5237_1 # 23 # 808 # -1 # ID=26838_1;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.248	NODE_33613_length_899_cov_8.5237_1	23	808	-	Strict	500	510.76	OXA-85	100.0	3001780	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAAAAAGTTTATTTTAGTGATGTTATTATTTATGTTCTCGATTATTTCTTTTGGTAATGAAAATCAATTTATGAAAGAGATTTTTGAAAGAAAAGGTTTAAACGGAACTTTTGTTGTTTATGATTTAAAAAATGATAAAATTGATTATTATAATTTGGATAGAGCTAATGAGAGATTTTATCCTGCTTCATCATTTAAAATTTTTAATACTTTGATAGGATTAGAAAATGGGATAGTAAAAAATGTTGATGAAATGTTTTATTATTATGACGGTTCTAAAGTTTTTCTTGATTCATGGGCAAAAGATTCGAATTTAAGATATGCAATAAAAGTATCTCAAGTTCCAGCTTATAAAAAGCTTGCAAGAGAATTGGGAAAAGAAAGAATGCAAGAAGGATTAAATAAATTAAATTATGGAAATAAGGAAATAGGTAGTGAGATTGATAAGTTTTGGTTAGAAGGTCCATTAAAAATAAGTGCAATGGAACAAGTTAAATTATTAAATCTATTATCACAGTCGAAACTTCCTTTTAAATTAGAAAATCAAGAACAAGTAAAAGATATTACGATTTTAGAGAAAAAAGATGATTTTATTTTACATGGAAAAACTGGGTGGGCTACTGATAATATAGTTGTTCCTATTGGTTGGTTTGTAGGTTGGATAGAAACTTCTGATAATATATATTCATTTGCTATTAATTTAGATATTTCTGATAGTAAATTTTTACCTAAACGTGAAGAAATTGTAAGAGAATATTTCAAAAATATAAATGTTATAAAATAA	VKKFILVMLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	102.76	gnl|BL_ORD_ID|270|hsp_num:0	289
NODE_33864_length_893_cov_3.08473_2 # 759 # 893 # 1 # ID=26988_2;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.481	NODE_33864_length_893_cov_3.08473_2 	759	893	+	Loose	2300	22.3274	evgS	40.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAAATCATGTTTGCATTGTGTTCGGCCATGTTGGCTTCTGCTGCGTCTGCAGCTGTTTATAAAGTGGACGAATTCCATGCCAATGCCCGCTTTGCCATCGACCATTTCAACACCAGCACCAACGTCGGC	MKKIMFALCSAMLASAASAAVYKVDEFHANARFAIDHFNTSTNVG	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	3.76	gnl|BL_ORD_ID|1261|hsp_num:0	1318
NODE_34982_length_866_cov_3.08015_2 # 777 # 866 # 1 # ID=27607_2;partial=01;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.333	NODE_34982_length_866_cov_3.08015_2 	777	866	+	Loose	1000	20.7866	cmlB	37.5	3002698	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATGAACCATTAGATATTATATTAAAATCTGTCAGAAAGGTATGGAGAGCGTGCTATCAATGCGCCTATGGAAGTTATTTCGTATAT	MNEPLDIILKSVRKVWRACYQCAYGSYFVY	MRSKNCNWRYSLAVTVLLLSPFDLLASLGMDMYLPAVPFMPHALGTTAGTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLAGGAAYVAASIGLVVTSSAGVFLGFRILQACGASACLVATFATVRDIYAGRKESNVIYGLLGSMLAMVPAIGPLLGAVIDTWFGWRAIFAFLGLGMIAALTAAWRLWPETRVQRPAALQWSQLLLPIKHLNFWLYTVCYAAGMGSFFVFFSIAPGLMMGRQGMSQFGFSLLFATVAIAMMLAARFMGRVIAKWGSLSALRMGMGCLIAGAVLLVITELWIPQSVLGFIAPMWLVGVGVATAVSVAPNGALRGFDHIAGAVTAVYFCLGGLLLGSVGTLIISLLPRDTAWPVIAYCLVLATIVLGLSCVSRARDLRGHGEYDAVART	7.33	gnl|BL_ORD_ID|461|hsp_num:0	486
NODE_44701_length_690_cov_2.17008_2 # 471 # 689 # 1 # ID=32630_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.571	NODE_44701_length_690_cov_2.17008_2 	471	689	+	Loose	300	22.7126	vanXYL	26.09	3002968	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGAACTTCGAGGAAATAGTAAAGCACCGCCGTGCTATCCGCTACTATGATCCCGAGAAGCCTCTAGATACTGCTCGTGTCGAGCACTGCCTTCGTCTAGCTTCTCTTGCCCCTACGAGCTCCAACCTTCAGCTCTGGGAGTGCTACCATATCACCGACCCCGCTGTCATCGCTTCTCTTGCCCCCGCCTGCTTCTCGCAGACGGCGGTCACCACTGCC	MNFEEIVKHRRAIRYYDPEKPLDTARVEHCLRLASLAPTSSNLQLWECYHITDPAVIASLAPACFSQTAVTTA	MDNDYKYYLQLVNKQYPWQINNGSKKMVRVPYTDKEIYLDAVVVEHLIQLIETIQLQEKIEIVDGYRTIDEQKELWEFSLKDRGKRYTHDYVAYPGCSEHHTGLALDIGLKKTAHDIIAPKFNGEEAKKFLEHMKDYGFILRYPPNKKKVTGIAYEPWHFRYVGVPHSQIITQQAWTLEEYIAFLHTVGEKVS	37.82	gnl|BL_ORD_ID|1792|hsp_num:0	1872
NODE_56791_length_551_cov_2.14315_1 # 1 # 549 # -1 # ID=38130_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.392	NODE_56791_length_551_cov_2.14315_1 	1	549	-	Strict	1700	25.409	LpeB	100.0	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TATAAGAAGAATGGTGCGGTAAACATTCCGAATACAGCTGATGTTATTCTAAATGATAAGAAGAAAACTTCGAAAGAAGTAACGGTTACTCCACCTAAACCAAAAGAACCAACTGTTTCTAAGAAGATTAACAACACCTTGGATAGTCTGGTAACCTTCGATGGTCAACCATACACTTACAACATCACAACAGCTGTGCCAAGTGATGTAGCAGGCTACAAGAAATTTGTCATTAGTGATAAGCTGGATGCCGATCTCGAATTTGATGGACAAGCAAGCATCAGCGGTCCATTGGCAGACGTCTTTGAAATCCAAACAAATGGTCAAACTGTTACTGCAACAGTTAAAGAAGGTAAGTTCGCAGAACTCGCGAAATATTCATTCGTCGAACTGACTATTCCAGCAAAAGTTAAAGCTGGTGTGACAGGTAAGACTATTGAAAACAAGGCTAAGATTTCATTTACTAATGAAAACAATGTGGCTAAGGAAGTTGAGTCAAATCCAGTAACGGTGACTCCTCCACCAGTAACTAAGAAGATCAATGACAAC	YKKNGAVNIPNTADVILNDKKKTSKEVTVTPPKPKEPTVSKKINNTLDSLVTFDGQPYTYNITTAVPSDVAGYKKFVISDKLDADLEFDGQASISGPLADVFEIQTNGQTVTATVKEGKFAELAKYSFVELTIPAKVKAGVTGKTIENKAKISFTNENNVAKEVESNPVTVTPPPVTKKINDN	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	18.05	gnl|BL_ORD_ID|2308|hsp_num:0	2759
NODE_59847_length_524_cov_4.08102_2 # 375 # 524 # -1 # ID=39346_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.533	NODE_59847_length_524_cov_4.08102_2 	375	524	-	Loose	400	22.7126	QnrB71	69.23	3002783	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	TTCGACTTGAACCACCGCCCTGCCCGTATCGGGCGCAACCCGAAAACCGGCGAACGCGTGGAAGTGCCTGAAAAGCATGTTCCTCACTTCAAACCGGGTAAAGAGTTGCGTGAGCGTGTAGACTTGGCATTGCAAGAAAGTGCTCATTAA	FDLNHRPARIGRNPKTGERVEVPEKHVPHFKPGKELRERVDLALQESAH	MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG	22.90	gnl|BL_ORD_ID|363|hsp_num:0	388
NODE_61560_length_509_cov_2.22026_1 # 110 # 508 # -1 # ID=39991_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.293	NODE_61560_length_509_cov_2.22026_1 	110	508	-	Loose	500	24.2534	OXA-60	24.49	3001808	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	AGAAAACTTCTTGAAAAAATAAGAGAAAAACTGGCAATGAAAAAAATTGAAAATCCAGAAGGCGAGAATGGAAATAAAAGTGAAAGCGAAAATATAGAACAAAAGTCATCGTTCTCAGAAATAGAACATCTTGAAAATTCAGGAACGTCTGTAAAGTCCAGAAAACCAGAAGAATTGACAATAGATTTTCAAATTTCAAAAGAGCCAAAGCAAAAGGATGAAAATTTTAAAGTAAAAGATTCTAAAAAAATAATAGAAAAAGGGGAAATAGATTCTAAAAATGAGGAACAAGAAATTGAAAAGCAAACCGAAGAAGCAATAGAAATATCAGAAGTGGAAGATTCTGAAAGTAGTGGAAAAAAAGTTAGATATGAAGACGGAACTTGGAAATTTTTCTAG	RKLLEKIREKLAMKKIENPEGENGNKSESENIEQKSSFSEIEHLENSGTSVKSRKPEELTIDFQISKEPKQKDENFKVKDSKKIIEKGEIDSKNEEQEIEKQTEEAIEISEVEDSESSGKKVRYEDGTWKFF	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	48.71	gnl|BL_ORD_ID|38|hsp_num:0	47
NODE_1674_length_10669_cov_6.88072_2 # 679 # 3420 # 1 # ID=1673_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.596	NODE_1674_length_10669_cov_6.88072_2 	679	3420	+	Strict	1500	1522.29	Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones	84.43	3003928	protein variant model	S91F	n/a	fluoroquinolone antibiotic; nybomycin	antibiotic target alteration	fluoroquinolone resistant gyrA	ATGAGCAGCACCCACGACCACCGGTTTGCCAAAGAAACCATCCCCGTCAGCCTCGAAGAGGAAATGCGCAAAAGCTATCTCGATTACGCCATGTCTGTAATCGTCGGCCGCGCGCTGCCCGATGTGCGCGACGGCCTGAAACCTGTGCACCGCCGCGTGCTTTACGCCATGCACGAGCTGAAAAACAACTGGAACAGCGCATACAAAAAATCCGCCCGCGTGGTCGGCGACGTTATCGGTAAATACCACCCACACGGCGATTTCGCGGTGTACCAAACCATCGTCCGCATGGCGCAGCCGTTTTCCATGCGCTATATGCTGGTGGACGGGCAGGGCAACTTCGGCTCGGTGGACGGAGATGCGGCGGCGGCTATGCGTTACACCGAAATCCGCATGGCGAAAATCGCCCACGAAATGCTGGCCGACATTGAAGAAGAAACCGTCAATTTCGGCGACAACTACGACGGCAGCGAACGCGAGCCGCTGGTACTGCCCACACGCTTCCCCGCCCTCTTGGTGAACGGCTCCGAAGGCATTGCCGTGGGCATGGCGACCAGCATTCCGCCGCATAACCTGCGCGATACGCTTGCAGGCTGCCTGAAACTTTTGAACGACCCTGAAACCGGCATCGACGAACTCATCGACATCGTCAAAGCCCCCGACTTCCCCACCGGCGCCACCATTTACGGCTTAACCGGCATCCGCGCGGGCTACCAGACCGGCCGCGGCCGCGTGGTCATCCGCAGCAAATCGCACATCGAACCCATCGGCAAAAACGGCGAGCGCGAAGCGATTGTGGTCGATGAAATCCCGTATCAGGTGAACAAATCCAAGCTGGTGGAAAAAATCGGCGAATTGGTGCGCGAAAAAACCGTGGAAGGCATTGCCGAGTTGCGCGACGAATCCGACAAAGACGGCACGCGCATCGTCATCGAGCTCAAACGCGGCGAAAACGCCGAAGTGGTGCTGAACCAGCTGTACAAACTCACCCAGCTGCAAGACAGCTTCGGCATCAATATGGTGGCCCTGGTCGACGGCCAGCCGCGCCTGTTGAATTTGAAGCAGATTCTGGCCGAATTCCTGCGCCACCGCCGTGAAGTGGTTACCCGCCGCACCCTGTTCCGCCTGAAAAAAGCGCGGCACGAAGGCCACATCGCCGAAGGCAAAGCCGTGGCGCTTTCCAATATCGACCCGATGATTCAGCTCATCAAAGAATCCGCCGATGCAGCCGAAGCCAAAGCCAAGCTGTTGGCGCGGTCGTGGCAATCGGGCCTGGTGGGCGACATGCTCAGCCGCACCGATTTGGATTTGAATATGGCGCGCCCCGAAGGGCTACCTGAAAACCTCGGCCTGCGCGAAGACGGCTATTATTTGAGCGATTTACAAGCCGACGCCATCCTACGCATGAGCCTGCGCAACCTCACCGGCCTCGACCAAGACACCATCCTCGCCGACTACAAAGCTATCATGGCGCAGATTATCGACTTCCTGGATATTTTGGCCAAGCCCGAGCGCATCACCCAAATCATCCGCGACGAGCTCATCGAAATCAAAACCAATTTCGGCGACCCGCGCCGCAGCGAAATCAACCCGTTCGGCGGCGACATCGCCGACGAAGACCTGATTCCGCCGCGCGAAATGGTGGTTACCCTCACCCACGGCGGCTACATCAAAACCCAGCCCACCACCGACTACCAAGCCCAGCGGCGCGGCGGACGCGGCAAGCAGGCCGCCGCCACCAAAGACGAAGACTTCATCGAAACCCTGTTTGTGGCCAACACCCACGACTACCTGATGTGCTTCACCAACCACGGCCGCTGCCACTGGATTAAAGTTTATAAATTGCCAGAAGGCGGGCGCAACTCGCGCGGCCGCCCGATCAACAACGTTATCCAGCTGGACGAAAACGAAAAAGTCTCCGCCATCCTGCCCGTACGCGACTTCCCCGAAGACGAATACGTTTTCTTCGCCACCGCCATGGGCGTGGTGAAAAAAGTGCAGCTTTCCGCGTTTAAAAACGTGAGCAAAGTCGGCATCAAAGCCATCGCCCTCAAAGAAGGCGACAGCCTGGTGGGCGTGGCGCGCACCTCCGGCCGCAACGACATCATGCTCTTCTCCAACCTCGGCAAAGCCATCCGCTTCAACGAATATTGGGAGCGCAGCAGCGACGACGAAGAAACCGGCGACGACAACGACACCGAAATTTCAGGTAGCCAGGAAGACGACAACGCCGAAAGCGCCCCCATCAGCGGCAAACACGGCGTGCGCCCCAGCGGCCGCGGCAGCGGCGGCCTGCGCGGCATGAGACTGCCCGAAAACGGCCGCATCGTCAGCCTCATCACCTTCGCCCCCGAATGCGAGCAGAGCGAACTGCAAGTGCTCACCGCCACCGCCAACGGCTACGGCAAACGCACCCCGATTGCCAGCTACAGCCGCAAAAACAAAGGTGGCCAAGGCAATATCGCCATCAACACCGGCGAGCGTAACGGCGACCTAGTGGCCGCCACCCTGGTGAGCGAAAGCGACGACCTGATGCTGATCACCAGCGGTGGCGTACTCATCCGCACCAAGGTGGAACAAATCCGCGAAACCGGCCGCGCCGCCGCCGGCGTGAAGCTGATTAACCTGGACGAAGGCGAAACCCTCGTCAGCCTCGAGCGCGTAGCCGAAGAAGAGGACGACGAAGTACCAACCGCCGAAACCACAGCCGAAAGCCCGAGCCAAGAACAAGGCGAGGCTTAA	MSSTHDHRFAKETIPVSLEEEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELKNNWNSAYKKSARVVGDVIGKYHPHGDFAVYQTIVRMAQPFSMRYMLVDGQGNFGSVDGDAAAAMRYTEIRMAKIAHEMLADIEEETVNFGDNYDGSEREPLVLPTRFPALLVNGSEGIAVGMATSIPPHNLRDTLAGCLKLLNDPETGIDELIDIVKAPDFPTGATIYGLTGIRAGYQTGRGRVVIRSKSHIEPIGKNGEREAIVVDEIPYQVNKSKLVEKIGELVREKTVEGIAELRDESDKDGTRIVIELKRGENAEVVLNQLYKLTQLQDSFGINMVALVDGQPRLLNLKQILAEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDPMIQLIKESADAAEAKAKLLARSWQSGLVGDMLSRTDLDLNMARPEGLPENLGLREDGYYLSDLQADAILRMSLRNLTGLDQDTILADYKAIMAQIIDFLDILAKPERITQIIRDELIEIKTNFGDPRRSEINPFGGDIADEDLIPPREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDYLMCFTNHGRCHWIKVYKLPEGGRNSRGRPINNVIQLDENEKVSAILPVRDFPEDEYVFFATAMGVVKKVQLSAFKNVSKVGIKAIALKEGDSLVGVARTSGRNDIMLFSNLGKAIRFNEYWERSSDDEETGDDNDTEISGSQEDDNAESAPISGKHGVRPSGRGSGGLRGMRLPENGRIVSLITFAPECEQSELQVLTATANGYGKRTPIASYSRKNKGGQGNIAINTGERNGDLVAATLVSESDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEEEDDEVPTAETTAESPSQEQGEA	MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELKNNWNAAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQNFAMRYVLIDGQGNFGSVDGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSSGIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREGYKTGRGRVVIRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISELRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQILSEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLLARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGLDQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIADEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDYLMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFATAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEYWEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGKIVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAATLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESELSGASVISNVTEPEAEN	99.67	gnl|BL_ORD_ID|2190|hsp_num:0	2404
NODE_15356_length_1846_cov_2.52875_2 # 915 # 1667 # -1 # ID=14395_2;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=12bp;gc_cont=0.539	NODE_15356_length_1846_cov_2.52875_2 	915	1667	-	Strict	1500	483.797	Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones	95.04	3003928	protein variant model	D95G	T83I:2196, D87G:2851, S83I:1545, D87G:1545, D87G:2850, D105G:2462, D94G:1935, S95T:1935, E84G:212, A85T:2412, S80I:1450, E84G:1450, E91G:2405	fluoroquinolone antibiotic; nybomycin	antibiotic target alteration	fluoroquinolone resistant gyrA	ATGACCGACGCAACCATCCGCAACGACCATAAATTTGCACTTGAAACCCTGCCTGTCAGCCTTGAAGACGAAATGCGCAAGAGCTACCTCGATTACGCCATGAGCGTGATTGTGGGACGAGCCCTGCCGGATGTCCGCGACGGTCTCAAGCCGGTACACCGCCGCGTGTTGTACGCGATGCACGAGTTGAAAAACAACTGGAATTCCGCCTATAAAAAATCGGCGCGTATCGTCGGCGACGTTATCGGTAAATATCACCCCCACGGTGATATAGCCGTTTACGGCACCATCGTCCGCATGGCGCAAGACTTCTCCATGCGTTATGTACTGATTGACGGTCAGGGCAACTTCGGTTCTGTCGACGGCTTGGCCGCAGCAGCCATGCGTTATACCGAGATCCGCATGGAAAAAATTTCCCATGAAATGCTGGCGGATATTGAAGAAGAAACCGTCAACTTCGGCCCCAACTATGACGGCAGCGAACATGAGCCGCTGGTGTTGCCGACCCGTTTCCCGGCTCTGTTGGTAAACGGTTCGTCCGGTATTGCCGTCGGTATGGCAACCAATATCCCGCCGCACAATTTGGGCGATACCATCAATGCTTGCCTGCGTTTGTTGGATGAGCCTGAAACTGAAATCGACGAGCTGATCAACATTATCCAAGCACCCGATTTCCCAACCGGCGCAACTATTTATGGCTTGAGCGGCGTGCGCGAAGGCTATAAANNNNNNNNNNGTAGTGATGCGCGGTAA	MTDATIRNDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELKNNWNSAYKKSARIVGDVIGKYHPHGDIAVYGTIVRMAQDFSMRYVLIDGQGNFGSVDGLAAAAMRYTEIRMEKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPALLVNGSSGIAVGMATNIPPHNLGDTINACLRLLDEPETEIDELINIIQAPDFPTGATIYGLSGVREGYKXXXXSDAR	MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELKNNWNAAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQNFAMRYVLIDGQGNFGSVDGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSSGIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREGYKTGRGRVVIRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISELRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQILSEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLLARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGLDQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIADEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDYLMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFATAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEYWEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGKIVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAATLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESELSGASVISNVTEPEAEN	27.29	gnl|BL_ORD_ID|2190|hsp_num:0	2404
NODE_39959_length_765_cov_2.27746_2 # 649 # 765 # 1 # ID=30290_2;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=6bp;gc_cont=0.444	NODE_39959_length_765_cov_2.27746_2 	649	765	+	Strict	375	19.2458	Escherichia coli acrR with mutation conferring multidrug antibiotic resistance	100.0	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATAGATACCCATACACATTTATATTCAGAAGAATTTGATACCGACCGCGTTGAGATGATAGTGCGCGCAAAGGCAGCAGGCGTAACCCGTTGCTTTATCCCTGCTATTGATGCA	MIDTHTHLYSEEFDTDRVEMIVRAKAAGVTRCFIPAIDA	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	18.14	gnl|BL_ORD_ID|2160|hsp_num:0	2306
